verified SJR 0,492 · Q3 • database Scopus / SJR & Web of Science & Latindex indexed

Spain · Clarivate

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Drugs of Today

Drugs of Today is a peer-reviewed journal with a solid reputation of over 40 years in the scientific publications market. It is a valuable source of information on drugs introduced into the international market. Its updated monographs and articles keep the medical community abrea...

ISSN: 1699-3993

Publisher: Clarivate

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedLatindex

open_in_new Visit publisher site menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,492 Q3

H-index 59

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science Latindex

SJR Impact

0,492

H-index

Docs (year)

Docs 3y

117

Total refs

Cites 3y

224

Citable 3y

117

Cites/Doc 2y

2.06

Ref/Doc

0.0

Immediate OA

- €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Asthma entities

What to do with targeted IL-2

Comprehensive disease management for schizophrenia

Clopidogrel: A selective inhibitor of platelet ADP receptors

Clinical studies with reteplase

Clinical studies of riluzole in amyotrophic lateral sclerosis

Clinical results in the treatment of respiratory infections with moxifloxacin

Clinical experience with erlotinib in non-small-cell lung cancer (NSCLC)

Cilomilast

Carvedilol update. 4: Prevention of oxidative stress, cardiac remodeling and progression of congestive heart failure

Calcium as a treatment of osteoporosis

Asthma therapy: Basic and clinical research

SHOW MORE ARTICLES

Asthma severity: Histopathologic correlations

A new combination vaccine for measles, mumps, rubella and varicella

Asthma education, monitoring and environmental control

Argatroban: A direct thrombin inhibitor with reliable and predictable anticoagulant actions

Antiplatelet therapy: Glycoprotein IIb/IIIa receptor antagonists

Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients

An overview of salsalate as a potential antidiabetic therapy

Albiglutide for the treatment of type 2 diabetes mellitus

A single-pill combination of amlodipine besylate and atorvastatin calcium

A report from the American Society for Bone and Mineral Research 2014 Annual Meeting (September 12-15 - Houston, Texas, USA)

A report from the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD) (September 15-19, 2014 - Vienna, Austria)

A report from the 23rd European Academy of Dermatology and Venereology Congress (October 8-12 - Amsterdam, The Netherlands)

FAQs

Drugs of Today has an SJR of 0,492 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Drugs of Today is 30%.

Drugs of Today

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Drugs of Today?

What is the APC / publication cost?

What is the acceptance rate?